盟科药业
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
First Subject Enrolled in Phase 1 Study of MRX-5 2023-11-20 18:34
MicuRx announces poster presentation and participation in ID Week 2023 Conference 2023-10-11 23:33
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil 2023-09-22 16:41
Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc. 2023-02-08 16:05
China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection 2021-06-03 22:15
1